Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Resource Type
Article
Authors
Sun, Jong-Mu ; Shen, Lin ; Shah, Manish A ; Enzinger, Peter ; Adenis, Antoine ; Doi, Toshihiko ; Kojima, Takashi ; Metges, Jean-Philippe ; Li, Zhigang ; Kim, Sung-Bae ; Cho, Byoung Chul ; Mansoor, Wasat ; Li, Shau-Hsuan ; Sunpaweravong, Patrapim ; Maqueda, Maria Alsina ; Goekkurt, Eray ; Hara, Hiroki ; Antunes, Luis ; Fountzilas, Christos ; Tsuji, Akihito ; Oliden, Victor Castro ; Liu, Qi ; Shah, Sukrut ; Bhagia, Pooja ; Kato, Ken
Source
In The Lancet 28 August-3 September 2021 398(10302):759-771
Subject
Primary Research Articles
Language
ISSN
0140-6736